Summary
The relationship among blood lipids, haemostatic and fibrinolytic parameters have been evaluated, during a follow-up study, in 27 non-insulin dependent (type II) diabetic patients. Upon recruitment, and in periodical controls, we observed that plasma triglycerides and VLDL levels correlated inversely, and HDL directly, with the fibrinolytic activity of plasma and euglobulin precipitate. Furthermore triglycerides and VLDL correlated directly with factor VIII antigen (vWFAg). After 5 years in the study, 12 patients (44%) had macroangiopathic complications, and 9 of these subjects showed persistently high levels of triglycerides (above 2.36 mmol/l). These haemostatic and lipid components, however, do not influence the progression of diabetic retinopathy and nephropathy. The alterations of lipid, haemostatic and fibrinolytic parameters and their possible relationships seem to play an important role in the occurrence of diabetic macroangiopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham EC, Huff TA, Cope ND, Wilson JB, Bramsome ED, Huisman THJ (1978) Determination of the glycosylated haemoglobins with a new microcolumn procedure. Diabetes 27: 931–937
Albrink MJ, Lavietes PH, Man EB (1963) Vascular disease and serum lipids in diabetes mellitus: observation over thirthy years (1931–1961). Ann Intern Med 58: 305–323
Allein CC, Poon LS, Chan CSG, Richmond W, Fu PL (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470–475
Arbogast BW, Lee GM, Raymond TL (1982) In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum. Diabetes 31: 593–599
Biggs R (1972) Human blood coagulation, haemostasis and thrombosis. Blackwell, Oxford London, p 614
Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476–482
Christe M, Fritschi J, Lammie B, Trah TH, Marbet GA, Berger W, Duckert F (1984) Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thrombos Haemostas 52: 138–143
Collen D (1980) On the regulation and control of fibrinolysis. Thrombos Haemostas 43: 77–89
Colwell JA, Wincour PD, Lopes-Virella M, Halushka PV (1983) New concept about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med (Suppl. 5 b) 67: 67–80
Fritschi J, Christe M, Lammie B, Marbet GA, Berger W, Duchert F (1984) Platelet aggregation, β-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy. Thrombos Haemostas 52: 326–329
Gamba G, Grignani G, Montera V, Perotti G, Ragone L, Ascari E (1983) Activators and inhibitors of the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations. La Ricerca Clin Lab 13: 337–345
Grignani G, Gamba G, Geroldi D, Pacchiarini L, Solerte SB, Ferrari E, Ascari E (1981) Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complications. Thrombos Haemostas 46: 648–651
Hamsten A, Wiman B, de Faire U, Blombäck M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New Eng J Med 313: 1557–1563
Ingram GI (1952) The determination of plasma fibrinogen by the clot-weight method. Biochem J 51: 583–585
Jones RL, Peterson CM (1981) Haematologic alterations in diabetes mellitus. Am J Med 70: 339–352
Laurell C (1966) Quantitative extimation of protein by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45–52
Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet I: 1050–1054
Mustard JF, Packham MA (1984) Platelets and diabetes mellitus. N Engl J Med 311: 665–667
Nilsson IM, Hedner U, Pandolfi M (1979) The measurement of fibrinolytic activities. IV Fibrin plate method. In: Markwardt F (ed) Fibrinolytic and antifibrinolytic. Springer, Berlin Heidelberg New York, pp 112–116
Noble RP, Hatch FF, Mazzimas JA, Lindgren FT, Jensen LC, Adamson GL (1969) Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultracentrifugation. Lipids 4: 55–61
Reckless JP, Betteridge DJ, Wu P, Payne B, Galton DJ (1978) High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1: 883–886
Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 369–377
Simpson HCR, Meade CW, Stirling Y, Mann JI, Chakrabarti R, Woolf L (1983) Hypertriglyceridemia and hypercoagulability. Lancet I: 786–789
Stout RW (1982) Glucose inhibits replication of cultured human endothelial cells. Diabetologia 23: 436–439
Stuart MJ, Gerrard JM, White JF (1980) Effect of cholesterol on production of thromboxane B2 by platelets in vitro. N Engl J Med 302: 6–10
The lipid research clinics coronary primary prevention trial results. In: (1984) Reduction in incidence of coronary heart disease. JAMA 251: 351–364
Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr (1984) Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 311: 953–959
Weimann BJ, Lorch E, Baumgartner HR (1984) High glucose concentrations do not influence replication and prostacyclin release of human endothelial cells. Diabetologia 27: 62–63
Wilhelsen L, Svardsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311: 501–505
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gamba, G., Solerte, S.B., Grignani, G. et al. Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. Blut 56, 257–260 (1988). https://doi.org/10.1007/BF00320285
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320285